Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1986 1
1987 1
1988 4
1989 2
1990 2
1991 3
1992 3
1997 1
1999 7
2000 9
2001 4
2002 7
2003 7
2004 2
2005 6
2006 5
2007 8
2008 7
2009 15
2010 9
2011 14
2012 8
2013 20
2014 18
2015 13
2016 17
2017 19
2018 22
2019 19
2020 25
2021 23
2022 16
2023 12
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

323 results

Results by year

Filters applied: . Clear all
Page 1
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial.
Zhong WZ, Wang Q, Mao WM, Xu ST, Wu L, Wei YC, Liu YY, Chen C, Cheng Y, Yin R, Yang F, Ren SX, Li XF, Li J, Huang C, Liu ZD, Xu S, Chen KN, Xu SD, Liu LX, Yu P, Wang BH, Ma HT, Yang JJ, Yan HH, Yang XN, Liu SY, Zhou Q, Wu YL. Zhong WZ, et al. Among authors: liu zd. J Clin Oncol. 2021 Mar 1;39(7):713-722. doi: 10.1200/JCO.20.01820. Epub 2020 Dec 17. J Clin Oncol. 2021. PMID: 33332190 Free PMC article. Clinical Trial.
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).
Zhang C, Sun YX, Yi DC, Jiang BY, Yan LX, Liu ZD, Peng LS, Zhang WJ, Sun H, Chen ZY, Wang DH, Peng D, Chen SA, Li SQ, Zhang Z, Tan XY, Yang J, Zhao ZY, Zhang WT, Su J, Li YS, Liao RQ, Dong S, Xu CR, Zhou Q, Yang XN, Wu YL, Zhang ZM, Zhong WZ. Zhang C, et al. Among authors: liu zd. Cell Rep Med. 2024 Jul 16;5(7):101615. doi: 10.1016/j.xcrm.2024.101615. Epub 2024 Jun 18. Cell Rep Med. 2024. PMID: 38897205 Free PMC article. Clinical Trial.
(E)-2-[(2-Chloro-benzyl-idene)amino]-isoindoline-1,3-dione.
Xu HJ, Jiang XY, Sheng LQ, Liu ZD. Xu HJ, et al. Among authors: liu zd. Acta Crystallogr Sect E Struct Rep Online. 2011 Dec 1;67(Pt 12):o3184. doi: 10.1107/S1600536811044898. Epub 2011 Nov 5. Acta Crystallogr Sect E Struct Rep Online. 2011. PMID: 22199705 Free PMC article.
Iron chelator chemistry.
Liu ZD, Liu DY, Hider RC. Liu ZD, et al. Adv Exp Med Biol. 2002;509:141-66. doi: 10.1007/978-1-4615-0593-8_8. Adv Exp Med Biol. 2002. PMID: 12572993 Review. No abstract available.
323 results